Arch Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
- Paid Up Capital ₹ 3.90 Cr
- Company Age 21 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 100.00 Cr
- Satisfied Charges ₹ 7.75 Cr
- Revenue Growth -90.93%
- Profit Growth -118.05%
- Ebitda -24.64%
- Net Worth -0.03%
- Total Assets -0.05%
About Arch Life Sciences
Arch Life Sciences Limited (ALSL) is a Public Limited Indian Non-Government Company incorporated in India on 15 December 2003 and has a history of 21 years and two months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Sibra Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 3.90 Cr.
The company currently has active open charges totaling ₹100.00 Cr. The company has closed loans amounting to ₹7.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ajit Kamath, Chetan Shah, and Rajendra Kaimal serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239TG2003PLC042232
- Company No.
042232
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
15 Dec 2003
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Arch Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajit Kamath  | Director | 02-Apr-2007 | Current |
| Chetan Shah | Director | Current | |
| Rajendra Kaimal | Director | 02-Apr-2007 | Current |
Financial Performance of Arch Life Sciences.
Arch Life Sciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 90.93% decrease. The company also saw a substantial fall in profitability, with a 118.05% decrease in profit. The company's net worth dipped by a decrease of 0.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arch Life Sciences?
In 2023, Arch Life Sciences had a promoter holding of 58.46% and a public holding of 41.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Arch Pharmalabs LimitedAjit Kamath and Rajendra Kaimal are mutual person
- Arch Pharmachem Ltd
Ajit Kamath, Chetan Shah and 1 more are mutual person
Tack Commosales LlpAjit Kamath is a mutual person
- Arch Agro Industries Private Limited
Ajit Kamath and Rajendra Kaimal are mutual person
- Amra Renal Care Limited
Ajit Kamath and Rajendra Kaimal are mutual person
- Arch Finechemicals Limited
Ajit Kamath, Chetan Shah and 1 more are mutual person
Charges (Loans)
₹100.00 Cr
₹7.75 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 57.00 Cr
- State Bank Of Patiala : 27.75 Cr
- Indusind Bank Ltd. : 15.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Nov 2008 | State Bank Of India | ₹57.00 Cr | Open |
| 01 Mar 2008 | Indusind Bank Ltd. | ₹15.25 Cr | Open |
| 01 Mar 2008 | State Bank Of Patiala | ₹27.75 Cr | Open |
| 29 Sep 2004 | Uco Bank | ₹7.75 Cr | Satisfied |
How Many Employees Work at Arch Life Sciences?
Unlock and access historical data on people associated with Arch Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arch Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arch Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
